Cambridge Investment Research Advisors’s Innovator Equity Defined Protection ETF - 1 Yr February ZFEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Sell
75,896
-9,395
-11% -$243K ﹤0.01% 1579
2026
Q1
$2.17M Buy
85,291
+10,600
+14% +$270K 0.01% 1528
2025
Q4
$1.9M Buy
74,691
+8,260
+12% +$207K 0.01% 1571
2025
Q3
$1.66M Sell
66,431
-6,892
-9% -$170K ﹤0.01% 1644
2025
Q2
$1.79M Buy
73,323
+25,236
+52% +$603K 0.01% 1507
2025
Q1
$1.14M Buy
+48,087
New +$1.15M ﹤0.01% 1757

Other funds holding ZFEB

Cambridge Investment Research Advisors's ZFEB Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Innovator Equity Defined Protection ETF - 1 Yr February (ZFEB) stake by 11% in Q2 2026, selling an estimated $243K and leaving 75,896 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

Cambridge Investment Research Advisors first reported a position in ZFEB in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.17M in Q1 2026. 32 funds tracked by Wall St. Rank hold ZFEB as of Q2 2026.

  • Cambridge Investment Research Advisors held 75,896 shares of Innovator Equity Defined Protection ETF - 1 Yr February worth $1.97M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 9,395 Innovator Equity Defined Protection ETF - 1 Yr February shares in Q2 2026, an estimated $243K.
  • Innovator Equity Defined Protection ETF - 1 Yr February made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1579 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Equity Defined Protection ETF - 1 Yr February in Q1 2025 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's Innovator Equity Defined Protection ETF - 1 Yr February position peaked at $2.17M in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr February as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.